glp 1 compounding update Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide GLP-1 Shortage = Over -

Grisha, A.V

Wegovy, a higher-dose version approved for obesity, followed

Numerous case reports of adverse events with GLP-1 agonists have been published over the last two years

Whey protein was studied in a group of obese women pursuing weight loss

These effects are seen even outside of diabetes control.[ref] Decreased colon cancer mortality: A 5-year mortality study in colon cancer patients showed that GLP-1 RA use decreased mortality risk by 60% in obese patients.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)